Michel Shamy Selected Research

Ischemic Stroke

2/2024	Benefits of First Pass Recanalization in Basilar Strokes Based on Initial Clinical Severity.
1/2024	Sex-Based Analysis of Workflow and Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase Versus Tenecteplase.
1/2024	The prevalence of non-contrast CT imaging abnormalities in reversible cerebral vasoconstriction syndrome: A systematic review and meta-analysis.
11/2023	Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial.
1/2023	Safety and Efficacy of Tenecteplase Compared With Alteplase in Patients With Large Vessel Occlusion Stroke: A Prespecified Secondary Analysis of the ACT Randomized Clinical Trial.
1/2022	Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.
1/2022	Ethical Justification for Deferral of Consent in the AcT Trial for Acute Ischemic Stroke.
1/2020	tPA for Acute Ischemic Stroke and Its Controversies: A Review.
1/2020	Early Dabigatran Treatment After Transient Ischemic Attack and Minor Ischemic Stroke Does Not Result in Hemorrhagic Transformation.
1/2020	Is This Contrast? Is This Blood? An Agreement Study on Post-thrombectomy Computed Tomography Scans.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michel Shamy Research Topics

Disease

16	Stroke (Strokes) 02/2024 - 01/2019
11	Ischemic Stroke 02/2024 - 10/2019
6	Cerebral Hemorrhage 01/2024 - 12/2019
3	Carotid Stenosis (Carotid Artery Stenosis) 12/2023 - 11/2019
3	Hematoma 01/2021 - 01/2020
2	Hemorrhage 01/2021 - 12/2019
2	Infarction (Infarctions) 01/2021 - 01/2020
2	Transient Ischemic Attack 10/2020 - 01/2020
1	COVID-19 09/2023
1	Death (Near-Death Experience) 01/2022
1	Insulin Resistance 01/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Aneurysm (Aneurysms) 10/2019
1	Movement Disorders (Movement Disorder) 01/2018
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Vasculitis (Vasculitides) 01/2017
1	Coma (Comas) 12/2015

Drug/Important Bio-Agent (IBA)

8	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2024 - 01/2020
8	Tenecteplase FDA Link 01/2024 - 01/2022
2	CDTA (DCTA)IBA 11/2020 - 01/2020
2	TabletsIBA 01/2019 - 01/2019
1	Dihydrotachysterol (AT 10)IBA 01/2024
1	SolutionsIBA 02/2023
1	SDMIBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	Dabigatran FDA Link 01/2020
1	Hemostatics (Antihemorrhagics)IBA 12/2019
1	recombinant FVIIa (rFVIIa)FDA Link 12/2019
1	Factor VII (Proconvertin)IBA 12/2019
1	PlacebosIBA 01/2018
1	Milrinone (Primacor)FDA LinkGeneric 01/2017

Therapy/Procedure

8	Therapeutics 01/2024 - 01/2019
6	Thrombectomy 02/2024 - 10/2019
2	Endarterectomy (Thromboendarterectomy) 01/2021 - 11/2019
1	Carotid Endarterectomy 12/2023
1	Critical Care (Surgical Intensive Care) 09/2023
1	Mechanical Ventilators (Ventilator) 09/2023
1	Stroke Rehabilitation 01/2019
1	Extracorporeal Membrane Oxygenation 12/2015